---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-005966"
form_type: "8-K"
ticker: "SONM"
cik: "0001178697"
company_name: "DNA X, Inc."
filed_at: "2026-02-10T23:59:59+00:00"
generated_at: "2026-05-16T03:31:34.496999+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# DNA X appoints Mike Mulica as acting CEO; salary $450k, 50k RSUs; CFO Crolius gets 35k RSUs

## Summary
- Mike Mulica appointed acting CEO effective Feb 9, 2026; base salary raised to $450,000 retroactive to Jan 30.
- Mulica receives 50,000 RSUs vesting monthly over one year; COBRA reimbursement up to 12 months post-termination.
- CFO Clay Crolius amendment acknowledges Jan 23 asset sale as a triggering event for change in control.
- Crolius granted 35,000 RSUs vesting monthly over one year; COBRA reimbursement up to 6 months post-termination.

## SEC filing metadata
- accession: 0001493152-26-005966
- form_type: 8-K
- ticker: SONM
- cik: 0001178697
- company_name: DNA X, Inc.
- filed_at: 2026-02-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178697/000149315226005966/0001493152-26-005966-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178697/000149315226005966/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-005966
- JSON: https://secwatch.observer/filing/0001493152-26-005966.json
- Plain text: https://secwatch.observer/filing/0001493152-26-005966.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.